SPEAKING SESSION
From Real-World Evidence to Real-World Impact: Closing the Gap Between Insight and Action in Life Sciences
Thursday, Oct. 15, 2026, 11:15-11:45 AM
Real-world evidence is now central to life sciences decision-making, yet a gap remains between insight generation and real-world impact. Many organizations still struggle to understand how patients move through treatment pathways, how providers make decisions, and where variation affects therapy adoption.
In this session, Sandy Leonard, General Manager, Life Sciences, at Arcadia, explored how integrating longitudinal data can provide a clearer view of patient journeys, provider behavior, and treatment patterns. These insights can help identify missed patients, uncover variation in care, and better align clinical evidence with real-world practice.
The discussion also examined how to move beyond retrospective analysis by connecting insights to stakeholders who influence treatment decisions. Attendees heard practical approaches for translating RWE into action to support patient identification, provider engagement, and more effective use of evidence.
What Attendees Learned:
- The key limitations of traditional real-world evidence approaches, including gaps in understanding patient pathways, provider decision-making, and treatment variation
- How integrating longitudinal data sources can improve visibility into patient identification, treatment patterns, and real-world care dynamics
- Approaches for translating real-world evidence into action, including strategies to support provider engagement and improve alignment between evidence and real-world practice
